Article Text

other Versions

PDF
Long term survival in a patient with variant creutzfeldt- jakob disease treated with intraventricular pentosan polysulphate
  1. A Parry (allysonparry{at}hotmail.com)
  1. The Radcliffe Infirmary, Oxford, United Kingdom
    1. I Baker (ian.baker{at}orh.nhs.uk)
    1. The Radcliffe Infirmary, Oxford, United Kingdom
      1. R Stacey (richard.stacey{at}orh.nhs.uk)
      1. The Radcliffe Infirmary, Oxford, United Kingdom
        1. S Wimalaratna (wim{at}doctors.org.uk)
        1. The Great Western Hospital, Swindon, United Kingdom

          Abstract

          Variant Creutzfeldt-Jakob Disease (vCJD) is a devastating neurodegenerative disease which principally affects young adults (1). There is currently no cure for vCJD and no treatment that conclusively slows the progression of the disease

          • Variant Creutzfeldt-Jakob Disease
          • pentosan
          • polysulphate, survival

          Statistics from Altmetric.com

          Request permissions

          If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.